The impact of ABO blood groups and RhD status on systemic inflammation markers (Systemic Immune-Inflammation Index, Systemic Inflammation Response Index, and Pan-Immune-Inflammation Value) in a large cohort of healthy adults
Laboratory Medicine · 05.10.2026 · 57 (6)
DOI: 10.1093/labmed/lmag073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, online erschienen am 26.10.2026. Verfasst von Ali Osman Avci. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Lokman Hekim University, Ankara, Türkiye. Hauptthemen laut MEDLINE: ABO Blood-Group System, Rh-Hr Blood-Group System, Inflammation, Biomarkers. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and Pan-Immune-Inflammation Value (PIV) are composite, integrated biomarkers of host inflammatory status. Although ABO blood groups are linked to various systemic diseases, their influence on these novel indices remains unclear. This study evaluated the impact of ABO blood groups and Rh blood group, D antigen (RhD) status on SII, SIRI, and PIV in a rigorously screened healthy cohort.
Methods
We retrospectively analyzed the electronic health records of 923 healthy adults (396 male, 527 female) evaluated between 2021 and 2025. Inclusion required strict metabolic (hemoglobin A1c < 5.7%), organ function, and serologic stability. Multigroup comparisons across the 4 ABO blood groups were performed using the Kruskal-Wallis H test, whereas 2-group independent analyses for sex and RhD status were evaluated using the Mann-Whitney U test.
Results
No statistically significant differences were observed in SII, SIRI, or PIV scores across the 4 major ABO blood groups (P = .61, P = .498, and P = .61, respectively) or RhD status (SII, P = .34; SIRI, P = .06; and PIV, P = .33). Statistically significant sex-based dimorphism was identified: SII scores were higher in female individuals (P = .007), whereas SIRI scores were higher in male individuals (P = .04). Chronological age categories showed no statistically significant correlation with any index (P > .05).
Discussion
Systemic inflammatory indices are independent of ABO blood groups and RhD status in clinically healthy adults. The substantial sex-specific variations underscore the necessity of considering implementing sex-stratified reference intervals within laboratory information systems to enhance personalized clinical interpretation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Faculty of Medicine, Lokman Hekim University, Ankara, Türkiye.
ORCID-Profile: Ali Osman Avci
Zitieren
APA
Avci, A. O. (2026). The impact of ABO blood groups and RhD status on systemic inflammation markers (Systemic Immune-Inflammation Index, Systemic Inflammation Response Index, and Pan-Immune-Inflammation Value) in a large cohort of healthy adults. Laboratory Medicine, 57(6). https://doi.org/10.1093/labmed/lmag073
Vancouver
Avci AO. The impact of ABO blood groups and RhD status on systemic inflammation markers (Systemic Immune-Inflammation Index, Systemic Inflammation Response Index, and Pan-Immune-Inflammation Value) in a large cohort of healthy adults. Laboratory Medicine. 2026;57(6). doi:10.1093/labmed/lmag073
BibTeX
@article{Avci2026,
author = {Avci, Ali Osman},
title = {The impact of ABO blood groups and RhD status on systemic inflammation markers (Systemic Immune-Inflammation Index, Systemic Inflammation Response Index, and Pan-Immune-Inflammation Value) in a large cohort of healthy adults},
journal = {Laboratory Medicine},
year = {2026},
volume = {57},
number = {6},
doi = {10.1093/labmed/lmag073}
}
EUVIMED